NO161274C - Fremgangsm te for fremstilling av immuninterferon. - Google Patents

Fremgangsm te for fremstilling av immuninterferon.

Info

Publication number
NO161274C
NO161274C NO843750A NO843750A NO161274C NO 161274 C NO161274 C NO 161274C NO 843750 A NO843750 A NO 843750A NO 843750 A NO843750 A NO 843750A NO 161274 C NO161274 C NO 161274C
Authority
NO
Norway
Prior art keywords
interferon
immunin
procedure
making
purification
Prior art date
Application number
NO843750A
Other languages
English (en)
Other versions
NO161274B (no
NO843750L (no
Inventor
Susumu Honda
Hiromu Sugino
Hsiang-Fu Kung
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24128473&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO161274(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO843750L publication Critical patent/NO843750L/no
Publication of NO161274B publication Critical patent/NO161274B/no
Publication of NO161274C publication Critical patent/NO161274C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
NO843750A 1983-09-20 1984-09-19 Fremgangsm te for fremstilling av immuninterferon. NO161274C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53404083A 1983-09-20 1983-09-20

Publications (3)

Publication Number Publication Date
NO843750L NO843750L (no) 1985-03-21
NO161274B NO161274B (no) 1989-04-17
NO161274C true NO161274C (no) 1989-07-26

Family

ID=24128473

Family Applications (1)

Application Number Title Priority Date Filing Date
NO843750A NO161274C (no) 1983-09-20 1984-09-19 Fremgangsm te for fremstilling av immuninterferon.

Country Status (19)

Country Link
EP (1) EP0138087B1 (no)
JP (1) JP2592441B2 (no)
KR (1) KR940004544B1 (no)
AT (1) ATE33842T1 (no)
AU (1) AU590712B2 (no)
DE (1) DE3470747D1 (no)
DK (1) DK162604C (no)
ES (1) ES8606886A1 (no)
FI (1) FI80293C (no)
GB (1) GB2146998B (no)
GR (1) GR80405B (no)
HU (1) HU196461B (no)
IL (1) IL72986A (no)
MC (1) MC1627A1 (no)
NO (1) NO161274C (no)
NZ (1) NZ209588A (no)
PH (1) PH23241A (no)
PT (1) PT79232B (no)
ZA (1) ZA846554B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2164650A (en) * 1984-09-25 1986-03-26 Fujisawa Pharmaceutical Co Process for production of y-interferon
GB8508340D0 (en) * 1985-03-29 1985-05-09 Creighton T E Production of protein
DE19755960C1 (de) * 1997-12-16 1998-11-26 Hoechst Ag Verfahren zum Aufschluß von biologischem Material

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7404589A (nl) * 1974-04-03 1975-10-07 Stichting Rega V Z W Werkwijze voor het stabiliseren van interferon.
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
IL65475A0 (en) * 1981-04-17 1982-07-30 Meloy Lab Production of immune interferon and its mrna
IL63327A (en) * 1981-07-16 1985-11-29 Yeda Res & Dev Production of interferon beta1 and alpha-phage recombinants for its production in host bacteria
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
ZA831094B (en) * 1982-02-22 1983-11-30 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides
IL68100A0 (en) * 1982-03-24 1983-06-15 Takeda Chemical Industries Ltd Novel dna and use thereof
IL69851A0 (en) * 1982-09-30 1983-12-30 Japan Found Cancer Novel dna and recombinant plasmid containing the same
WO1984002129A1 (en) * 1982-11-22 1984-06-07 Takeda Chemical Industries Ltd Human immune interferon protein and process for its preparation
JPH0740925B2 (ja) * 1983-03-14 1995-05-10 協和醗酵工業株式会社 新規ヒトインタ−フエロン−γポリペプチド
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor

Also Published As

Publication number Publication date
AU590712B2 (en) 1989-11-16
FI80293C (fi) 1990-05-10
GB2146998A (en) 1985-05-01
ES8606886A1 (es) 1986-05-16
ES536028A0 (es) 1986-05-16
DK447784A (da) 1985-03-21
PH23241A (en) 1989-06-06
HUT35289A (en) 1985-06-28
KR850002285A (ko) 1985-05-10
PT79232A (en) 1984-10-01
EP0138087B1 (en) 1988-04-27
GB2146998B (en) 1987-10-07
DK162604C (da) 1992-05-11
FI80293B (fi) 1990-01-31
IL72986A0 (en) 1984-12-31
ZA846554B (en) 1985-04-24
GB8423748D0 (en) 1984-10-24
JP2592441B2 (ja) 1997-03-19
NO161274B (no) 1989-04-17
KR940004544B1 (en) 1994-05-25
PT79232B (en) 1986-11-18
DK447784D0 (da) 1984-09-19
FI843669A0 (fi) 1984-09-19
DK162604B (da) 1991-11-18
IL72986A (en) 1990-04-29
NO843750L (no) 1985-03-21
GR80405B (en) 1985-01-21
MC1627A1 (fr) 1985-09-26
EP0138087A1 (en) 1985-04-24
FI843669L (fi) 1985-03-21
JPS6169800A (ja) 1986-04-10
ATE33842T1 (de) 1988-05-15
NZ209588A (en) 1989-05-29
AU3330184A (en) 1985-03-28
HU196461B (en) 1988-11-28
DE3470747D1 (en) 1988-06-01

Similar Documents

Publication Publication Date Title
ATE60622T1 (de) Verfahren zur aufbereitung von immuninterferon.
AU577314B2 (en) Human y interferon fragment and production from recombinant microbes
NO161274C (no) Fremgangsm te for fremstilling av immuninterferon.
EP0185391A3 (en) Method for the purification of the hbc antigen and method for the measurement of hbc antibodies by using said purified hbc antigen